LAPTM4B
Basic information
Region (hg38): 8:97775057-97853013
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAPTM4B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 3 |
Variants in LAPTM4B
This is a list of pathogenic ClinVar variants found in the LAPTM4B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-97775784-C-T | Benign (Jan 19, 2018) | |||
8-97775803-G-C | not specified | Likely benign (Jun 03, 2024) | ||
8-97775833-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
8-97775858-G-A | not specified | Uncertain significance (Jan 25, 2023) | ||
8-97775872-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
8-97775926-C-G | not specified | Uncertain significance (Jan 31, 2024) | ||
8-97775935-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
8-97775936-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
8-97775937-C-CGGCGGGCTCCAGGCGA | not specified | Benign (Mar 29, 2016) | ||
8-97775979-C-G | not specified | Likely benign (Aug 02, 2021) | ||
8-97776032-C-G | not specified | Uncertain significance (May 15, 2023) | ||
8-97776047-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
8-97776094-G-C | not specified | Uncertain significance (Dec 20, 2022) | ||
8-97805403-G-A | Benign (Feb 02, 2018) | |||
8-97816062-G-A | not specified | Likely benign (Mar 07, 2023) | ||
8-97816072-G-T | not specified | Uncertain significance (May 05, 2023) | ||
8-97816076-A-G | not specified | Uncertain significance (Jun 06, 2023) | ||
8-97816173-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
8-97819170-A-G | not specified | Uncertain significance (Aug 05, 2023) | ||
8-97825061-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
8-97825139-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
8-97825146-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
8-97825152-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
8-97851418-G-A | not specified | Uncertain significance (Mar 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LAPTM4B | protein_coding | protein_coding | ENST00000445593 | 7 | 77957 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.28e-13 | 0.00701 | 125527 | 0 | 218 | 125745 | 0.000867 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.113 | 176 | 172 | 1.02 | 0.00000877 | 1984 |
Missense in Polyphen | 56 | 62.588 | 0.89473 | 770 | ||
Synonymous | -0.729 | 78 | 70.2 | 1.11 | 0.00000384 | 643 |
Loss of Function | -0.849 | 17 | 13.6 | 1.25 | 6.64e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00175 | 0.00175 |
Ashkenazi Jewish | 0.000699 | 0.000695 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000788 | 0.000739 |
European (Non-Finnish) | 0.000975 | 0.000959 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000610 | 0.000523 |
Other | 0.00312 | 0.00310 |
dbNSFP
Source:
- Function
- FUNCTION: Required for optimal lysosomal function (PubMed:21224396). Blocks EGF-stimulated EGFR intraluminal sorting and degradation. Conversely by binding with the phosphatidylinositol 4,5-bisphosphate, regulates its PIP5K1C interaction, inhibits HGS ubiquitination and relieves LAPTM4B inhibition of EGFR degradation (PubMed:25588945). Recruits SLC3A2 and SLC7A5 (the Leu transporter) to the lysosome, promoting entry of leucine and other essential amino acid (EAA) into the lysosome, stimulating activation of proton-transporting vacuolar (V)-ATPase protein pump (V-ATPase) and hence mTORC1 activation (PubMed:25998567). Plays a role as negative regulator of TGFB1 production in regulatory T cells (PubMed:26126825). Binds ceramide and facilitates its exit from late endosome in order to control cell death pathways (PubMed:26280656). {ECO:0000269|PubMed:21224396, ECO:0000269|PubMed:25588945, ECO:0000269|PubMed:25998567, ECO:0000269|PubMed:26126825, ECO:0000269|PubMed:26280656}.;
- Pathway
- Lysosome - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.718
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.69
Haploinsufficiency Scores
- pHI
- 0.488
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0396
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Laptm4b
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- endosome organization;endosome transport via multivesicular body sorting pathway;negative regulation of transforming growth factor beta1 production;regulation of lysosomal membrane permeability;negative regulation of lysosomal protein catabolic process;regulation of lysosome organization
- Cellular component
- lysosome;lysosomal membrane;endosome;early endosome;plasma membrane;membrane;integral component of membrane;late endosome membrane;multivesicular body membrane;cell projection;multivesicular body, internal vesicle
- Molecular function
- protein binding;kinase binding;ubiquitin protein ligase binding;ceramide binding;phosphatidylinositol bisphosphate binding